ArticleJournal of Korean medical science2024

Could Molnupiravir Be the First-Line Alternative Oral Antiviral Agent for COVID-19 Patients at High Risk?

Ji Yong LeePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.